D-1412-2012 Class II Terminated
FDA drug recall D-1412-2012 was initiated by GlaxoSmithKline Inc on Jun 4, 2012 and is designated Class II. Reason for recall: Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets. The recall status is terminated (terminated Sep 4, 2014). Affected quantity: 14,465 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 18, 2012
- Initiation Date
- Jun 4, 2012
- Termination Date
- Sep 4, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,465 bottles
Product description
Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18
Reason for recall
Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.
Distribution pattern
Nationwide
Code information
Lot #0ZP5128 exp; 8/2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1412-2012
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026